Ziyu Liu

Clinicopathologic characteristics and molecular subtypes of invasive papillary carcinoma of the breast: a large case study

Y. Niu, N. Liu, Shuhua Lv, 2012, Journal of Cancer Research and Clinical Oncology.

Abnormal expression of Nek2 and β‐catenin in breast carcinoma: clinicopathological correlations

Wei-dong Li, Y. Niu, Tieju Liu, 2011, Histopathology.

Effect of NIMA-related kinase 2B on the sensitivity of breast cancer to paclitaxel in vitro and vivo

Wei Zhang, Y. Niu, Honghong Shen, 2017, Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine.

Nek2C functions as a tumor promoter in human breast tumorigenesis.

Jing Zhang, Yun Niu, Fei Zhang, 2012, International journal of molecular medicine.

A retrospective study of breast cancer subtypes: the risk of relapse and the relations with treatments

Y. Niu, Q. Yu, Shu-ling Wang, 2011, Breast Cancer Research and Treatment.

SDCBP promotes pancreatic cancer progression by preventing YAP1 from β-TrCP-mediated proteasomal degradation

Yu Guo, Jing-yan Sun, Jingrui Yan, 2023, Gut.

Artificial intelligence-based comprehensive analysis of immune-stemness-tumor budding profile to predict survival of patients with pancreatic adenocarcinoma

Jingrui Yan, Tianxing Zhou, J. Hao, 2023, Cancer biology & medicine.

Irbesartan overcomes gemcitabine resistance in pancreatic cancer by suppressing stemness and iron metabolism via inhibition of the Hippo/YAP1/c-Jun axis

Song Gao, Jing-yan Sun, Xiufeng Zhang, 2023, Journal of Experimental & Clinical Cancer Research.